4Esler M. The sympathetic system and hypertension. Am J Hypertens, 2000, 13 : 99S-105S.
5Krum H,Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension. A multicentre safety and proof-of-principle cohort study. Lancet, 2009, 373: 1275-1281.
6Symplicity I-ITN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. Hypertension, 2011,57 : 911-917.
7Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomized controlled trial. Lancet, 2010, 376 : 1903-1909.
8Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension. Circulation, 2011, 123 : 1940-1946.
9胡春松 胡大一.健康的“种子”法则[J].太平洋论坛杂志,2005,1(6):76-76.
10Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 ; 289 (19) : 2560-2572.
3Rothwell PM. Limitations of the usual blood pressure hypothesis and importance of variability, instability and episodic hypertension[J].Lancet,2010,375(9718):938-948.
4Harrison DG, Guzik TJ, Lob HE, et al. Inflammation, immunity and hypertension [J].Hypertensi on,2011,57(2):132-140.
5The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke and mortality: an individual participant meta-analysis[J].Lancet, 2010,375 (9709): 132-140.
6Lakoski SG, Herrington DM, Siscovick DM, et al. C-reactive protein concentration and incident hypertension in young adults: the CARDIA study[J]. Arch Intern Med,2006,166 (3):345-349.
7Schillaci G, Pucci G, Parati G. Blood pressure variability: an additional target for antihypertension treatment?[J]. Hypertension, 2011,58(2): 133-135.
8Tatasciore A, Zimarino M, Renda G, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension [J].Hypertens Res, 2008, 31(12):2137-2146.
9Kim KI, Lee JH, Chang H J, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients [J].Circ J, 2008, 72 (2):293-298.
